Professional Summary

Professional Overview

William Noss is an accomplished financial executive with over 15 years of experience in the biopharmaceutical industry. As the Vice President of Finance at Dragonfly Therapeutics, Inc., he is responsible for leading the company's financial strategy, reporting, and operational efficiency initiatives.

Experience Summary

Current Role

As the VP of Finance at Dragonfly Therapeutics, Inc., William is responsible for overseeing the company's financial planning, budgeting, and analysis. He works closely with the executive team to drive financial decision-making and ensure the company's long-term financial stability and growth. Under his leadership, Dragonfly Therapeutics has achieved significant milestones, including securing a $100 million Series C funding round and expanding its pipeline of innovative immunotherapies.

Career Progression

Prior to his current role, William held several finance leadership positions in the biopharmaceutical industry. He served as the Chief Financial Officer at Pulmotect, Inc., where he played a crucial role in the company's successful $50 million Series B financing. Before that, he held various finance and accounting roles at Harmony Biosciences and Aevi Genomic Medicine, Inc., where he contributed to the companies' financial reporting, process improvements, and strategic initiatives.

William's early career experience includes positions at Telerx and ViroPharma Incorporated, where he honed his expertise in international finance and corporate auditing. His diverse background and deep understanding of the biopharmaceutical industry have enabled him to consistently drive financial excellence and support the growth of the companies he has served.

Academic Background

William holds a Bachelor of Science in Accounting from the University of Pennsylvania and is a Certified Public Accountant (CPA).

Areas of Expertise

• Financial planning and analysis

• Budgeting and forecasting

• Strategic financial decision-making

• Financial reporting and compliance

• Mergers, acquisitions, and capital raising

• Process improvement and operational efficiency

• Leadership and team management

Professional Impact

Throughout his career, William has proven his ability to navigate complex financial challenges and drive strategic initiatives that have a direct impact on the success of biopharmaceutical companies. His expertise in financial reporting, process optimization, and strategic decision-making has been instrumental in supporting the growth and financial stability of the organizations he has served.

Conclusion

With his extensive experience, strong financial acumen, and collaborative leadership style, William Noss is well-positioned to continue driving Dragonfly Therapeutics' financial strategy and contributing to the company's long-term success in the biopharmaceutical industry.